BASF SE
BASF SE, along with DIEM Labs, agreed to pay over $416,000 to settle FTC charges that they deceptively marketed dietary fish oil supplements as clinically proven to reduce liver fat in adults and children with non-alcoholic fatty liver disease (NAFLD). The FTC found the efficacy claims were unsubstantiated. The settlement funds were used to provide consumer refunds, and both companies were barred from the allegedly illegal conduct under final consent orders approved in June 2021.
Flagged claims (1)
clinically proven to reduce liver fat in adults and children with non-alcoholic fatty liver disease (NAFLD)
Required actions (3)
two companies, BASF SE and DIEM Labs, agreed to pay a total of more than $416,000 to settle FTC charges
The payment will enable the Commission to provide refunds to all consumers who bought either supplement.
They also were barred from the allegedly illegal conduct.
Does your site contain similar claims?
The free site audit scans your site against every entry in this Atlas. Most nutrition / supplements sites match 3-6 patterns.
Run my free site audit